|
|
PVCT Provectus Biopharmaceuticals
|
|
||
Re: Provectus Biopharmaceuticals Announces Acceptance of PV-10® Neuroendocrine Cancer Abstract at European Society for Medical Oncology (ESMO) Congress 2021That would be great if that happened, in fact I’m hoping for a lot of good things happening as soon as these ratchet warrants expire |
return to message board, top of board |